Repurposing FDA‐Approved Compounds for the Discovery of Glutaminyl Cyclase Inhibitors as Drugs Against Alzheimer's Disease

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource

Language: Englisch

Bibliographic citation: Repurposing FDA‐Approved Compounds for the Discovery of Glutaminyl Cyclase Inhibitors as Drugs Against Alzheimer's Disease ; year:2020
ChemistryOpen ; (2020)

Creator: Xu, Chenshu
Zou, Haoman
Yu, Xi
Xie, Yazhou
Cai, Jiaxin
Shang, Qi
Ouyang, Na
Wang, Yinan
Xu, Pan
He, Zhendan
Wu, Haiqiang

DOI: 10.1002/open.202000235

URN: urn:nbn:de:101:1-2021020510543319404821

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:38 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Xu, Chenshu
Zou, Haoman
Yu, Xi
Xie, Yazhou
Cai, Jiaxin
Shang, Qi
Ouyang, Na
Wang, Yinan
Xu, Pan
He, Zhendan
Wu, Haiqiang

Other Objects (12)

Repurposing FDA-approved drugs for anti-aging therapies

Hochschulschrift

Repurposing von FDA-approved drugs zur Therapie des humanen Cytomegalievirus

Repurposing FDA approved drugs against the human fungal pathogen, Candida albicans

Repurposing FDA approved drugs as radiosensitizers for treating hypoxic prostate cancer

QUADrATiC: scalable gene expression connectivity mapping for repurposing FDA-approved therapeutics

Repurposing FDA-approved drugs as inhibitors of therapy-induced invadopodia activity in glioblastoma cells

Repurposing of FDA approved ring systems through bi-directional target-ring system dual screening

Repurposing of approved cardiovascular drugs

Repurposing FDA-approved drugs targeting FZD10 in nasopharyngeal carcinoma: insights from molecular dynamics simulations and experimental validation

The First FDA-Approved Antibody-Drug Conjugate

Repurposing FDA‐Approved Drugs for Temozolomide‐Resistant IDH1 Mutant Glioma Using High‐Throughput Miniaturized Screening on Droplet Microarray Chip

Scaffold Searching of FDA and EMA-Approved Drugs Identifies Lead Candidates for Drug Repurposing in Alzheimer’s Disease

Repurposing FDA-approved drugs for anti-aging therapies

Hochschulschrift

Repurposing von FDA-approved drugs zur Therapie des humanen Cytomegalievirus

Repurposing FDA approved drugs against the human fungal pathogen, Candida albicans

Repurposing FDA approved drugs as radiosensitizers for treating hypoxic prostate cancer

QUADrATiC: scalable gene expression connectivity mapping for repurposing FDA-approved therapeutics

Repurposing FDA-approved drugs as inhibitors of therapy-induced invadopodia activity in glioblastoma cells

Repurposing of FDA approved ring systems through bi-directional target-ring system dual screening

Repurposing of approved cardiovascular drugs

Repurposing FDA-approved drugs targeting FZD10 in nasopharyngeal carcinoma: insights from molecular dynamics simulations and experimental validation

The First FDA-Approved Antibody-Drug Conjugate

Repurposing FDA‐Approved Drugs for Temozolomide‐Resistant IDH1 Mutant Glioma Using High‐Throughput Miniaturized Screening on Droplet Microarray Chip

Scaffold Searching of FDA and EMA-Approved Drugs Identifies Lead Candidates for Drug Repurposing in Alzheimer’s Disease

Repurposing FDA-approved drugs for anti-aging therapies

Hochschulschrift

Repurposing von FDA-approved drugs zur Therapie des humanen Cytomegalievirus

Repurposing FDA approved drugs against the human fungal pathogen, Candida albicans

Repurposing FDA approved drugs as radiosensitizers for treating hypoxic prostate cancer

QUADrATiC: scalable gene expression connectivity mapping for repurposing FDA-approved therapeutics

Repurposing FDA-approved drugs as inhibitors of therapy-induced invadopodia activity in glioblastoma cells

Repurposing of FDA approved ring systems through bi-directional target-ring system dual screening

Repurposing of approved cardiovascular drugs

Repurposing FDA-approved drugs targeting FZD10 in nasopharyngeal carcinoma: insights from molecular dynamics simulations and experimental validation

The First FDA-Approved Antibody-Drug Conjugate

Repurposing FDA‐Approved Drugs for Temozolomide‐Resistant IDH1 Mutant Glioma Using High‐Throughput Miniaturized Screening on Droplet Microarray Chip

Scaffold Searching of FDA and EMA-Approved Drugs Identifies Lead Candidates for Drug Repurposing in Alzheimer’s Disease

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Repurposing FDA‐Approved Compounds for the Discovery of Glutaminyl Cyclase Inhibitors as Drugs Against Alzheimer's Disease

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Repurposing FDA-approved drugs for anti-aging therapies

Repurposing von FDA-approved drugs zur Therapie des humanen Cytomegalievirus

Repurposing FDA approved drugs against the human fungal pathogen, Candida albicans

Repurposing FDA approved drugs as radiosensitizers for treating hypoxic prostate cancer

QUADrATiC: scalable gene expression connectivity mapping for repurposing FDA-approved therapeutics

Repurposing FDA-approved drugs as inhibitors of therapy-induced invadopodia activity in glioblastoma cells

Repurposing of FDA approved ring systems through bi-directional target-ring system dual screening

Repurposing of approved cardiovascular drugs

Repurposing FDA-approved drugs targeting FZD10 in nasopharyngeal carcinoma: insights from molecular dynamics simulations and experimental validation

The First FDA-Approved Antibody-Drug Conjugate

Repurposing FDA‐Approved Drugs for Temozolomide‐Resistant IDH1 Mutant Glioma Using High‐Throughput Miniaturized Screening on Droplet Microarray Chip

Scaffold Searching of FDA and EMA-Approved Drugs Identifies Lead Candidates for Drug Repurposing in Alzheimer’s Disease

Repurposing FDA-approved drugs for anti-aging therapies

Repurposing von FDA-approved drugs zur Therapie des humanen Cytomegalievirus

Repurposing FDA approved drugs against the human fungal pathogen, Candida albicans

Repurposing FDA approved drugs as radiosensitizers for treating hypoxic prostate cancer

QUADrATiC: scalable gene expression connectivity mapping for repurposing FDA-approved therapeutics

Repurposing FDA-approved drugs as inhibitors of therapy-induced invadopodia activity in glioblastoma cells

Repurposing of FDA approved ring systems through bi-directional target-ring system dual screening

Repurposing of approved cardiovascular drugs

Repurposing FDA-approved drugs targeting FZD10 in nasopharyngeal carcinoma: insights from molecular dynamics simulations and experimental validation

The First FDA-Approved Antibody-Drug Conjugate

Repurposing FDA‐Approved Drugs for Temozolomide‐Resistant IDH1 Mutant Glioma Using High‐Throughput Miniaturized Screening on Droplet Microarray Chip

Scaffold Searching of FDA and EMA-Approved Drugs Identifies Lead Candidates for Drug Repurposing in Alzheimer’s Disease

Repurposing FDA-approved drugs for anti-aging therapies

Repurposing von FDA-approved drugs zur Therapie des humanen Cytomegalievirus

Repurposing FDA approved drugs against the human fungal pathogen, Candida albicans

Repurposing FDA approved drugs as radiosensitizers for treating hypoxic prostate cancer

QUADrATiC: scalable gene expression connectivity mapping for repurposing FDA-approved therapeutics

Repurposing FDA-approved drugs as inhibitors of therapy-induced invadopodia activity in glioblastoma cells

Repurposing of FDA approved ring systems through bi-directional target-ring system dual screening

Repurposing of approved cardiovascular drugs

Repurposing FDA-approved drugs targeting FZD10 in nasopharyngeal carcinoma: insights from molecular dynamics simulations and experimental validation

The First FDA-Approved Antibody-Drug Conjugate

Repurposing FDA‐Approved Drugs for Temozolomide‐Resistant IDH1 Mutant Glioma Using High‐Throughput Miniaturized Screening on Droplet Microarray Chip

Scaffold Searching of FDA and EMA-Approved Drugs Identifies Lead Candidates for Drug Repurposing in Alzheimer’s Disease

Related objects

Reset password